Tips for coming off Mounjaro: a practical guide to stopping safely

Mounjaro's appetite-suppressing effects ease off after stopping — weight regain is common without an active plan, but not inevitable with the right support in place.
Tirzepatide has a half-life of roughly five days, so its action fades over several weeks after the last injection, not overnight.
Your prescriber should be involved in any dose reduction or stopping decision — this is not a medicine to pause unilaterally without clinical input.
Lifestyle habits built during treatment are the single most protective factor once treatment ends; nutrition, activity, and sleep all count.

If you are thinking about stopping Mounjaro, the most useful thing to know first is this: tirzepatide leaves your system gradually, but the appetite-regulating effects it produces do not transfer to your body permanently. Planning the transition carefully matters. Mounjaro is a prescription-only medicine, and any decision about stopping or reducing doses should be made with your prescriber, who can review your individual circumstances before you change anything. The sections below walk through what that process typically looks like, what to expect, and how to give yourself the best chance of keeping the progress you have made.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to plan stopping Mounjaro in a way that protects your progress

Step 1: Have an honest conversation with your prescriber before you change anything

The first step is not a change to your pen, it is a conversation. Your prescriber needs to know why you are considering stopping: is it cost, a planned pregnancy, a side effect, or simply a feeling that you have reached your goal? The answer shapes what happens next.

Some people assume that once they have lost the weight, stopping is straightforward. That is a reasonable assumption, and a gentle one to let go of. Clinical evidence is clear that the biology driving weight regain does not switch off when treatment ends; it reasserts itself gradually as tirzepatide clears your system. A prescriber can help you weigh that reality against your reasons for stopping, and decide whether a staged reduction, a maintenance dose, or a clean stop is the right call for you.

At nume, a real clinician reads every consultation, you can read about our clinical team if you want to know more about who is making those decisions. The general FAQs also cover common queries about ongoing care.

NHS England's guidance on weight-management injections is a useful reference for the kind of questions your prescriber will be working through with you.

Step 2: Understand what changes in your body as tirzepatide clears

Tirzepatide works by activating both GIP and GLP-1 receptors involved in appetite regulation and gastric emptying, as described in the NHS tirzepatide information pages. Its half-life is around five days, which means that after your last weekly injection, the medicine is still active for several weeks, fading rather than switching off. During that window, appetite typically begins to return before it reaches its pre-treatment baseline.

Gastric emptying, which slows on Mounjaro and contributes to the feeling of fullness, also returns to its previous pace. Many people notice hunger coming back in waves rather than all at once. Recognising this as a pharmacological change (not a personal failure) is genuinely useful. It means you can respond to it with intention rather than surprise.

You can read more about the physical effects of stopping Mounjaro and what the research says about what happens in the weeks and months after the last dose.

Step 3: Build the habits that do the heaviest lifting after treatment ends

This is where the real work sits, and most of it can start before you stop. Protein intake matters more once appetite returns fully, because it supports satiety and helps preserve muscle mass. Aim to keep protein prominent in each meal, your prescriber or a dietitian can help you set a specific target based on your weight and activity level. The NHS healthy weight guidance covers practical diet and activity principles that complement what a clinician advises.

Strength-based activity is worth prioritising specifically. Weight loss on GLP-1 and dual-agonist medicines can include some loss of lean mass, and resistance training during and after treatment helps offset that. You do not need a gym; bodyweight exercises at home count.

Sleep is often underestimated here. Poor sleep directly elevates hunger hormones. If sleep quality has been difficult, it is worth raising with your prescriber alongside the stopping conversation.

If weight regain after stopping is something you are worried about, the page covering Mounjaro, stopping, and weight gain looks at the evidence in more detail.

Step 4: Know what to watch for and when to get help

After stopping, most people experience a gradual return of appetite and, for some, weight regain over months. That is well-documented. What requires medical attention is a different category: if you experience unexpected or severe symptoms in the weeks after stopping (significant nausea, abdominal pain, or rapid changes in blood glucose if you also have type 2 diabetes) contact your GP or prescriber rather than waiting.

It is also worth knowing that if you started Mounjaro for a weight-related health condition such as hypertension or pre-diabetes, those conditions may need monitoring more actively once treatment ends, since some of the metabolic benefit of tirzepatide may reduce over time.

If you are wondering about the broader context of what stopping involves, the coming off Mounjaro overview brings together the key considerations in one place, and if you have been following the coming of Mounjaro story from the start, that context can also help frame the stopping decision. And if your situation involves tirzepatide from another prescriber and you are looking at your options, our treatment overview explains what a private clinical review involves.

For those at an earlier stage (still deciding whether tirzepatide is right for them at all) the tirzepatide information page covers the medicine from the beginning, including detail on dose escalation and what to expect at each stage, and if you are curious about where treatment can lead, the page on 17mg tirzepatide explains the highest available dose and who it may be suitable for. Coming off a treatment is its own chapter, but it helps to understand the full picture of what the medicine does and does not do.

If you have specific questions or your circumstances feel complicated, speaking directly to a prescriber is the most useful next step. Start a free consultation with our prescribers and get a clinical view on your situation the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions